Author details
Author Molgo J |
Available item(s) by this author (24)
sorted by (Issue date descending, Issue date descending, System of projection of the document ascending) | Add the result to the basket | Make a suggestion | Refine your search
Article
Boex M ; Cottin S ; Halliez M ; Bauche S ; Buon C ; Sans N ; Montcouquiol M ; Molgo J ; Amar M ; Ferry A ; Lemaitre M ; Rouche A ; Langui D ; Baskaran A ; Fontaine B ; Messéant J ; Strochlic L | United States | 17/05/2022Article
Sigoillot SM, Author ; Bourgeois F ; Karmouch J ; Molgo J ; Dobbertin A ; Chevalier C ; Houlgatte R ; Leger J ; Legay C | 2016Article
Messéant J, Author ; Dobbertin A ; Girard E ; Delers P ; Manuel M ; Mangione F ; Schmitt A ; Le Denmat D ; Molgo J ; Zytnicki D ; Schaeffer L ; Legay C ; Strochlic L | 2015Article
Bauche S ; Molgo J ; Rouche A ; de la Porte S ; Pignol B ; Christen Y ; Hantaï D ; Koenig J | 2008The aging process in mammals, including humans, is associated with a decline in neuromuscular function and performance. The main aspect of this decline, known as sarcopenia, is the reduction in skeletal muscle mass, related to a loss of muscle s[...]Article
Vignaud A ; Fougerousse F ; Mouisel E ; Bertrand C ; Bonafos B ; Molgo J ; Ferry A ; Chatonnet A | 2008Accès au résumé PubMed / to PubMed abstractArticle
Stum M ; Girard E ; Bangratz M ; Bernard V ; Herbin M ; Vignaud A ; Ferry A ; Davoine CS ; Echaniz-Laguna A ; Rene F ; Marcel C ; Molgo J ; Fontaine B ; Krejci E ; Nicole S | 2008Accès au résumé PubMed / to PubMed abstract 17/11/2008 - Syndrome de Schwartz-Jampel : un premier modèle de souris avec neuromyotonie Le syndrome de Schwartz-Jampel (SJS) est une maladie neuromusculaire caractérisée par une neuromy[...]Article
Chevessier F ; Girard E ; Molgo J ; Sönke B ; Koenig J ; Hantaï D ; Witzemann V | 2008Accès au résumé PubMed / to PubMed abstractArticle
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Stum M ; Bangratz M ; Girard E ; Bernard V ; Davoine CS ; Tabti N ; Willer JC ; Echaniz-Laguna A ; Rene F ; Marcel C ; Fontaine B ; Molgo J ; Krejci E ; Nicole S | 2008Schwartz-Jampel syndrome (SJS) is a recessive disorder characterized by neuromyotonia with complex repetitive discharges at electromyography (EMG). SJS results from hypomorphic mutations of perlecan, a ubiquitous proteoglycan secreted within bas[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Stum M ; Girard E ; Davoine CS ; Molgo J ; Tabti N ; Willer JC ; Fontaine B ; Krejci E ; Nicole S | 2005Communication n° 640. Schwartz-Jampel syndrome (SJS) is a rare autosomal recessive human disease. Patients suffer from functional handicap with myotonia and chondrodystrophy that appear during chidlhood. We previously demonstrated that SJS was d[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Molgo J ; Adams D ; Colasante C ; Jaimovich E | 2005Communication n° 573 At the neuromuscular junction (NMJ) not yet well explored is the possible role of neuromuscular activity mediated via an IP3 cascade in perisynaptic Schwann cells, and in the postsynaptic elements of the NMJ. The well docume[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Girard E ; Camp S ; Taylor P ; Krejci E ; Molgo J | 2005Communication n° 559 At the neuromuscular junction (NMJ) two closely related enzymes can hydrolyze acetylcholine (ACh): acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Although the role of AChE in regulating the duration of ACh act[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Molgo J ; Liberona J ; Cardenas C ; Debitus C ; Laurent D ; Jaimovich E | 2005Communication n° 567 Xestospongin B, a macrocyclic bis-1-oxaquinolizidine alkaloid extracted from the marine sponge Xestospongia exigua, was highly purified and tested for its ability to block inositol 1,4,5-trisphosphate (IP3)-induced calcium r[...]Article
Article
Ishigaki K, Author ; Nicolle D ; Krejci E ; Corringer PJ ; Molgo J ; Massoulié J ; Koenig J ; Guicheney P ; Fardeau M ; Eymard B ; Hantaï D | 2001Article
Tarabal O ; Caldero J ; Ribera J ; Sorribas A ; Lopez R ; Molgo J ; Esquerda J | 1996Accès au résumé PubMed / to PubMed abstractArticle
Juzans P ; Comella JX ; Molgo J ; Faille L ; Angaut Petit D | 1996Pour voir le résumé sur PubMed, cliquez iciArticle
Juzans P ; Molgo J ; Faille L ; Angaut Petit D | 1996Accès au résumé PubMed / to PubMed abstractArticle
Meunier FM ; Colasante C ; Faille L ; Gastard M ; Molgo J | 1996Accès au résumé PubMed / to PubMed abstractArticle
Angaut Petit D ; Juzans P ; Molgo J ; Faille L ; Seagar MJ ; Takahashi M ; Shoji-Kasai Y | 1995Article
Poulain B ; Molgo J ; Thesleff S | 1995The eight clostridial neurotoxins so far known, tetanus toxin (TeNT) and botulinum neurotoxins (BoNTs) types A-G, have been extensively studied, not only because they are responsible for the clinical manifestations of tetanus and botulism, but a[...]